- Case-Based Modules
- Initial Evaluation
- Dermatologic Manifestations
- Oral Manifestations
- OIs: Prophylaxis
- OIs: Treatment
- Antiretroviral Rx
- Antiretroviral Rx: Resistance
- Antiretroviral Rx: Adverse Effects
- Drug-Drug Interactions
- Postexposure Prophylaxis
- Perinatal Transmission
- Special Populations
- Prevention for Positives
- Challenging Unknowns
- Resource-Limited Settings
- Interactive Tutorials
- Routine HIV Screening
- Oraquick Advance Rapid HIV Test
- HIV Integration
- This program is funded through Health Resources and Services Administration, US Department of Health and Human Services.
Postexposure Prophylaxis
Question | Discussion | References | CME Credit
Case 5: Nonoccupational Exposure to HIV
You answered:
 |
Nevirapine (Viramune) should not be used as part of an antiviral PEP regimen after sexual exposure to HIV. |
|---|
This answer is correct. Nevirapine is contraindicated for use in PEP regimens following occupational or nonoccupational exposures to HIV because of the unacceptably high risk of serious liver and skin toxicity when this agent is administered to HIV-negative individuals.
Copyright © 2004-2013 University of Washington